Dihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer
Background:
Dihydrotanshinone I (DHTS) was previously reported to exhibit the most potent anti-cancer activity among several tanshinones in colon cancer cells. Its cytotoxic action was reactive oxygen species (ROS) dependent but p53 independent.
Purpose:
To further study the anti-cancer activity of DHTS and its molecular mechanisms of action in colon cancer both in vitro and in vivo.
Methods:
Caspase activity was detected by fluorescence assay. Apoptosis was detected by flow cytometry and TUNEL assay. Protein levels were analyzed by western blotting. Knockdown of target gene was achieved by siRNA transfection. Formation of LC3B puncta and activation of caspase-3 were detected by confocal fluorescence microscope. In vivo anti-colon cancer activity of DHTS was observed in xenograft tumors in NOD/SCID mice.
Results:
Anti-colon cancer activity of DHTS by inducing apoptosis and autophagy was observed both in vitro and in vivo. Mitochondria mediated caspase dependent pathway was essential in DHTS-induced cytotoxicity. The apoptosis induced by DHTS was suppressed by knockdown of apoptosis inducing factor (AIF), inhibition of caspase-3/9 but was increased after knockdown of caspase-2. Meantime, knockdown of caspase-2, pretreatment with Z-VAD-fmk or NAC (N-Acety-L-Cysteine) efficiently inhibited the autophagy induced by DHTS. A crosstalk between cytochrome c and AIF was also reported.
Conclusion:
DHTS-induced caspase and ROS dependent apoptosis and autophagy were mediated by mitochondria in colon cancer. DHTS could be a promising leading compound for the development of anti-tumor agent or be developed as an adjuvant drug for colon cancer therapy.
Insights
Dihydrotanshinone I (DHTS) effectively combats colon cancer by triggering apoptosis and autophagy through mitochondria. This natural compound shows promise as a novel anti-tumor agent or adjuvant therapy.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Dihydrotanshinone I (DHTS) demonstrates potent anti-cancer activity in colon cancer cells.
- Its cytotoxic effects are dependent on reactive oxygen species (ROS) but independent of p53.
Purpose of the Study:
- To investigate the anti-cancer effects of DHTS in colon cancer.
- To elucidate the molecular mechanisms underlying DHTS action in vitro and in vivo.
Main Methods:
- Assessed caspase activity, apoptosis (flow cytometry, TUNEL assay), and protein levels (western blotting).
- Utilized siRNA for gene knockdown and confocal microscopy for LC3B puncta and caspase-3 activation.
- Evaluated in vivo anti-colon cancer activity in xenograft mouse models.
Main Results:
- DHTS exhibited anti-colon cancer activity by inducing apoptosis and autophagy both in vitro and in vivo.
- Mitochondria-mediated, caspase-dependent pathways were crucial for DHTS-induced cytotoxicity.
- Apoptosis was modulated by AIF, caspase-3/9, and caspase-2, with observed crosstalk between cytochrome c and AIF.
Conclusions:
- DHTS induces apoptosis and autophagy via mitochondrial pathways, involving caspases and ROS.
- DHTS presents potential as a leading compound for anti-tumor drug development or as an adjuvant therapy for colon cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

